Granules India is currently trading at Rs. 280.40, up by 5.70 points or 2.07 % from its previous closing of Rs. 274.70 on the BSE.
The scrip opened at Rs. 276.00 and has touched a high and low of Rs. 283.70 and Rs. 276.00 respectively. So far 47756 shares were traded on the counter.
The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 294.00 on 12-Feb-2014 and a 52 week low of Rs. 90.15 on 22-Mar-2013.
Last one week high and low of the scrip stood at Rs. 280.75 and Rs. 262.00 respectively. The current market cap of the company is Rs. 566.25 crore.
The promoters holding in the company stood at 48.86 % while Institutions and Non-Institutions held 1.62 % and 49.42 % respectively.
Granules India’s board of directors at its meeting held on February 20, 2014 has approved the Scheme of Arrangement involving amalgamation of Auctus Pharma with Granules India.
Granules India is a fast growing pharmaceutical manufacturing company with world class facilities and is committed to manufacturing excellence, quality and customer service. The Company produces Finished Dosages (FDs), Pharmaceutical Formulation Intermediates (PFIs) and Active Pharmaceutical Ingredients (APIs) for quality conscious customers in the regulated and semi-regulated markets.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1797.80 |
Dr. Reddys Lab | 1213.90 |
Cipla | 1486.30 |
Lupin | 2069.95 |
Zydus Lifesciences | 948.70 |
View more.. |